产后乳腺癌年轻女性总生存率最低
该研究汇总科罗拉多年轻女性乳腺癌队列与乳腺癌健康差异研究共2519例病例,随访15年,分析产次、年龄及临床因素与总生存(OS)的关联。结果显示,45岁前诊断的产后乳腺癌(PPBC)患者OS最低(p<0.0001),校正混杂因素后PPBC仍为预后不良的独立因素。
要点
- 45岁前诊断的产后乳腺癌患者总生存最低(p<0.0001)。
- 45岁前未产患者OS较PPBC患者好1.6倍(HR=0.61,95%CI 0.42-0.87)。
- ≤35岁未产患者OS较PPBC患者好2.3倍(HR=0.44,95%CI 0.23-0.84)。
核心结论
- 产后状态似乎是年轻乳腺癌患者预后不良的主要驱动因素,在≤35岁诊断和I期患者中关联最强。
研究设计与样本
- 汇总科罗拉多年轻女性乳腺癌队列与乳腺癌健康差异研究数据,共2519例病例,随访15年,分析产次、年龄及临床因素与总生存的关联。
主要发现
- 45岁前诊断的PPBC患者OS最低(p<0.0001),而45岁前诊断的未产患者OS与45-65岁诊断者无差异(不论产次状态)。
- 校正研究地点、种族/民族、临床分期、诊断年份并按雌激素受体状态分层后,PPBC仍为OS不良的独立因素。
- 45岁前诊断的未产患者OS较PPBC患者好1.6倍(HR=0.61,95%CI 0.42-0.87),在I期乳腺癌中生存差异更明显(HR=0.30,95%CI 0.11-0.79)。
- ≤35岁诊断的未产患者OS较PPBC患者好2.3倍(HR=0.44,95%CI 0.23-0.84)。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Women diagnosed with breast cancer prior to age 45 years (<45y) and within the first 5 years postpartum (postpartum breast cancer, PPBC) have the greatest risk for distal metastatic recurrence. METHODS: Pooling data from the Colorado Young Women Breast Cancer cohort and the Breast Cancer Health Disparities Study (N = 2519 cases), we examined the association of parity, age, and clinical factors with overall survival (OS) of breast cancer over 15 years of follow-up. RESULTS: Women with PPBC diagnosed at <45y had the lowest OS (p < 0.0001), while OS of nulliparous cases diagnosed at <45y did not differ from OS of cases diagnosed at 45-65y regardless of parity status. After adjustment for study site, race/ethnicity, clinical stage, year of diagnosis and stratification for oestrogen receptor status, PPBC remained an independent factor associated with poor OS. Among cases diagnosed at <45y, nulliparous cases had 1.6 times better OS (hazard ratio (HR) = 0.61, 95%CI 0.42-0.87) compared to those with PPBC, with a more pronounced survival difference among stage I breast cancers (HR = 0.30, 95%CI 0.11-0.79). Among very young women diagnosed at age ≤35y, nulliparous cases had 2.3 times better OS (HR = 0.44, 95%CI 0.23-0.84) compared to PPBC. CONCLUSION: Our results suggest that postpartum status is the main driver of poor prognosis in young women with breast cancer, with the strongest association in patients diagnosed at age ≤35y and in those with stage I disease.
引用
- Shagisultanova E, Gao D, Callihan E, et al. Overall survival is the lowest among young women with postpartum breast cancer. Eur J Cancer. 2022. PMID: 35525161. doi:10.1016/j.ejca.2022.03.014
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。